Concepedia

Rosa M. Álvarez

RM

Statistics

Publications

13

Citations

496

H-Index

12

Active since

2003

Affiliations

Spanish National Cancer Research Centre(Current)

Janssen (Belgium)

Johnson & Johnson (United States)

Rosa M. Álvarez is an author at Spanish National Cancer Research Centre specializing in medicinal chemistry, pharmacology, and drug discovery.

ORCID

Publications per year

2003–2021

13

Publications

13

Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies

Edurne San José‐Eneriz, Xabier Agirre, Obdulia Rabal et al. · Nature Communications · 2017 · 170 citations · Full text

, , +17

Discovery of a New Series of Centrally Active Tricyclic Isoxazoles Combining Serotonin (5-HT) Reuptake Inhibition with α<sub>2</sub>-Adrenoceptor Blocking Activity

José Ignacio Andrés, Jesús Alcázar, José Manuel Alonso Segura et al. · Journal of Medicinal Chemistry · 2004 · 50 citations · Full text

, , +16

Hit to lead evaluation of 1,2,3-triazolo[4,5-b]pyridines as PIM kinase inhibitors

Joaquı́n Pastor, Julen Oyarzábal, Gustavo Saluste et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 44 citations · Full text

, , +12

Imidazo[1,2-a]pyrazines as novel PI3K inhibitors

Sonia Martı́nez, Ana Isabel Hernández, Carmen Varela et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 32 citations · Full text

, , +9

Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists

Julen Oyarzábal, Trevor Howe, Jesús Alcázar et al. · Journal of Medicinal Chemistry · 2009 · 32 citations · Full text

, , +17

1–5 of 13